Status:
COMPLETED
The Role of Central Serotonergic and Adrenergic Systems in the Effectiveness of DNIC (Diffuse Noxious Inhibitory Control
Lead Sponsor:
Rambam Health Care Campus
Conditions:
Healthy
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The role of central serotonergic and adrenergic systems in the effectiveness of DNIC (Diffuse Noxious Inhibitory Control) will be tested before and after taking Duloxetine and Placebo in a double blin...
Eligibility Criteria
Inclusion
- Healthy volunteers
- age 18-80
- no chronic disease
Exclusion
- Subjects who suffer from chronic pain / pain syndrome
- use of anti-depressant or anti-psychotic drugs
- food/ drugs sensitivity
- breast feeding
Key Trial Info
Start Date :
August 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2012
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT00660751
Start Date
August 1 2007
End Date
April 1 2012
Last Update
October 11 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rambam Health Care Campus
Haifa, Israel, 31096